Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Astec LifeSciences Limited (NSE: ASTEC), ISIN INE563J01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ASTEC last traded at ₹570.55 (+0.57%), with a 52-week range of ₹513.40 to ₹941.75 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 71.96%, FIIs 0.02%, DIIs 3.34%, mutual funds 3.02%.
EquiSense Score (ECS): 33/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.